Gait Analysis of Hemiparetics Adults Patients With Quadripod Cane and Rolling Cane

May 17, 2022 updated by: Maillard Berengere, University of Liege

After stroke, a lot of patients present an hemiparesis and gait disorders. They need walking aids like quadripod cane or rolling cane.

The quadripod cane confers a great stability but implies a walk in 3 times, thus consume more energy. The pause time necessary for the displacement (uplift) of the cane disappear with the Wheeleo.

The investigators will study many spatio-temporal parameters to determine which one allows to decrease the walking speed.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Hemiparesis affects 65% of stroke patients and cause gait disorders. During rehabilitation, patients often need technical aids to the the return to walk.

For example, they can use the quadripod cane and the rolling cane, called Wheeleo. Regarding the first one, as its name indicate, there are 4 feet while the other model has 4 wheels.

Deltombe and al. proved that the walking speed is higher with a rolling cane. The investigators will recruited stroke patients and study many spatio-temporal parameters with a gait analysis system, when participants are walking with the two walking aids.

Participants will achieve 6 minutes walking test and a 10 meters walking test, with a wearable inertial systems on their shoes.

The investigators wish to reveal which spatio-temporal parameters most influence walking speed.

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age > 18 years
  • Hemiparesis following a stroke
  • Be able to walk with a quadripod cane independently
  • Be able to walk with the rolling cane independently
  • Be able to follow instructions

Exclusion Criteria:

  • cognitive impairment
  • acute orthopedic impairment
  • other pathologies affecting walking (Parkinson's disease, severe polyneuropathy,...)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Rolling can
Gait analysis with rolling cane
Device: Gait analysis with rolling cane
6 minutes walking test 10 meters walking test Before this experimentation, we will fix wearables sensors on the shoes.
Active Comparator: Quadripod can
Gait analysis with quadripod cane
Device: Gait analysis with quadripod cane
6 minutes walking test 10 meters walking test Before this experimentation, we will fix wearables sensors on the shoes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
10 meters walking test at fast speed
Time Frame: 2 days
Calculate the walking speed
2 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
6 minutes walking test at spontaneous speed
Time Frame: 2 days
Spatio-temporals factors analysis (symmetry, time of unipodal/bipodal stance station,...)
2 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Liege

Investigators

  • Principal Investigator: Berengere Maillard, University of Liege

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 26, 2022

Primary Completion (Anticipated)

March 31, 2023

Study Completion (Anticipated)

March 31, 2023

Study Registration Dates

First Submitted

December 6, 2021

First Submitted That Met QC Criteria

December 6, 2021

First Posted (Actual)

December 20, 2021

Study Record Updates

Last Update Posted (Actual)

May 24, 2022

Last Update Submitted That Met QC Criteria

May 17, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Liege Hospital Ethic Comittee

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe